This Canadian company’s AI tool could help drugmakers cut risk in late-stage cancer trials Using data from past trials, Altis Labs showed superior survival prediction in lung cancer patients

https://www.statnews.com/2025/03/26/altis-labs-ai-model-ipro-analyzes-lung-colorectal-cancer-scans-clinical-trial-risk/